Nureca Limited has announced the relocation of its registered office within Mumbai, marking a significant administrative development for the healthcare and consumer products company. The shift became effective on December 10, 2025, as communicated to both major stock exchanges.

Office Relocation Details

The company has moved its registered office from the eastern suburbs to the western part of Mumbai. This transition represents a strategic administrative decision that may enhance operational efficiency and accessibility.

Regulatory Compliance

Nureca Limited has fulfilled its regulatory obligations by promptly informing the stock exchanges about this corporate action. The notification was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to disclose material events and corporate developments.

The communication was signed by Nishu Kansal, Company Secretary and Compliance Officer (Membership No. A33372), ensuring proper authorization and compliance with corporate governance standards. The digital signature was applied on December 10, 2025, at 17:02:23.

Corporate Structure

While the registered office has been relocated, Nureca Limited maintains its correspondence office at SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh-160009. The company continues to operate under CIN L24304MH2016PLC320868 and can be reached at phone number 91-172-5292900.

Stock Exchange Information

The company has requested both BSE Limited and National Stock Exchange of India Limited to take note of this information and arrange for its proper dissemination to market participants.

This administrative change reflects the company's ongoing operational adjustments and commitment to maintaining transparent communication with regulatory authorities and stakeholders.

Nureca Limited has announced the dissolution of its wholly owned subsidiary, Nureca Healthcare Private Limited, effective December 3, 2025. This corporate action, carried out under Section 248 of the Companies Act, 2013, marks a significant development in the company's structure.

Key Points of the Announcement

• Subsidiary Dissolved: Nureca Healthcare Private Limited
• Effective Date: December 3, 2025
• Legal Basis: Section 248 of the Companies Act, 2013
• Regulatory Compliance: Informed BSE and NSE as per SEBI regulations

Implications and Context

The striking off of a wholly owned subsidiary often indicates a strategic move by the parent company. While the specific reasons for this action have not been disclosed, such decisions are typically made to streamline operations, reduce administrative overhead, or realign business focus.

Regulatory Compliance

Nureca Limited has adhered to regulatory requirements by promptly informing the stock exchanges. This transparency is crucial for maintaining investor trust and complying with the Securities and Exchange Board of India (SEBI) regulations.

What This Means for Investors

Investors should note that this corporate action might have implications for Nureca Limited's financial structure and operations. However, without further details, it's premature to speculate on the exact impact on the company's future performance or stock value.

Shareholders and potential investors are advised to:

• Monitor any subsequent announcements from the company for additional context
• Review future financial reports to understand any material changes resulting from this dissolution
• Consult with financial advisors if seeking personalized investment advice related to this development

As the market digests this information, it will be important to observe any changes in Nureca Limited's stock performance and analyst recommendations in the coming days.